Baker McKenzie advised South Pole Holding on successfully completing their purchase of 100% of the shares in Carbonsinkgroup. Carbonsink operates a consulting business providing net-zero decarbonisation and climate risk management strategies for companies. It was founded
Tags :Kevin Ardüser
Baker McKenzie advised Chord Therapeutics (Chord) and its shareholders on the sale of all the shares in Chord to Merck KGaA (Merck). The acquisition is subject to regulatory clearances. This strategic acquisition will enable Merck
Sika has signed a definitive agreement to acquire MBCC Group, the former BASF Construction Chemicals, from an affiliate of Lone Star Funds, a global private equity firm, for a consideration of CHF 5.5 billion (EUR 5.2 billion).
Baker McKenzie advised International Schools Partnership (ISP) in the acquisition of two new schools — the British School of Geneva and Ecole Mosaic — in the Geneva region. ISP considers both schools a great addition to the
Anjarium Biosciences, a Swiss biotech company, recently closed a CHF 55.5 million (USD 61 million) Series A financing round, co-led by Gimv and Abingworth. The fundraising also saw significant participation from Omega Funds, Pfizer Ventures and surveyor
Baker McKenzie acted as legal counsel to Artum, the Swiss industrial holding company, on the sale of 100% of their shares to Storskogen, a Swedish privately owned company that acquires and operates well-managed and profitable businesses
